70 results on '"Gasser, Thomas"'
Search Results
2. Potential impacts of pandemics on global warming, agricultural production, and biodiversity loss
3. Human Dopaminergic Neurons Lacking PINK1 Exhibit Disrupted Dopamine Metabolism Related to Vitamin B6 Co-Factors
4. Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s disease
5. Potential Consequences of Low Biopsy Core Number in Selection of Patients With Prostate Cancer for Current Active Surveillance Protocols
6. Intraoperative microelectrode recording for the delineation of subthalamic nucleus topography in Parkinson’s disease
7. Establishing the role of rare coding variants in known Parkinson's disease risk loci
8. Evaluation of Hardware-related Geometrical Distortion in Structural MRI at 7 Tesla for Image-guided Applications in Neurosurgery
9. Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia?
10. Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis
11. The transcription factor PITX3 is associated with sporadic Parkinson's disease
12. DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders
13. Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variants
14. [11C]PIB binding in Parkinson's disease dementia
15. Parkinson patient fibroblasts show increased alpha-synuclein expression
16. Variation in PARK10 is not associated with risk and age at onset of Parkinson's disease in large clinical cohorts
17. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer
18. Retroperitoneoscopic management of caliceal diverticular calculi
19. Urine Detection of Survivin is a Sensitive Marker for the Noninvasive Diagnosis of Bladder Cancer
20. IS THERE A CLINICAL RELEVANCE OF PARTIAL ANDROGEN DEFICIENCY OF THE AGING MALE?
21. Growth of Mycobacteria in Urine Determined by Isothermal Microcalorimetry: Implications for Urogenital Tuberculosis and Other Mycobacterial Infections
22. The Addition of Urinary Urokinase-Type Plasminogen Activator to Urinary Nuclear Matrix Protein 22 and Cytology Improves the Detection of Bladder Cancer
23. Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease
24. A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease
25. Chapter 8 - Aorta
26. Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization
27. LACK OF DIAGNOSTIC TOOLS TO PROVE ERECTILE DYSFUNCTION: CONSEQUENCES FOR REIMBURSEMENT?
28. URINARY LEVEL OF NUCLEAR MATRIX PROTEIN 22 IN THE DIAGNOSIS OF BLADDER CANCER: : EXPERIENCE WITH 130 PATIENTS WITH BIOPSY CONFIRMED TUMOR
29. Variable response to intracavernous prostaglandin E 1 testing for erectile dysfunction
30. MEMORY FUNCTION IS ASSOCIATED WITH TAU PATHOLOGY IN PARKINSON’S DISEASE
31. NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases
32. Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study
33. Contributors
34. Further delineation of the association signal on chromosome 5 from the first whole genome association study in Parkinson's disease
35. Reduction of susceptibility-induced signal losses in multi-gradient-echo images: Application to improved visualization of the subthalamic nucleus
36. NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases
37. 2174 THE INFLUENCE OF INCREASED MAXIMUM POWER OUTPUT ON THE OUTCOME OF PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE WITH THE GREENLIGHT LASER - THREE-YEAR RESULTS OF A COMPARISON BETWEEN THE 80-W KTP AND THE 120-W HPS-LASER
38. 2173 PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE WITH THE 120-W HPS GREENLIGHT LASER VERSUS LASER VAPORIZATION OF THE PROSTATE WITH THE 980 NM 200-W HIGH INTENSITY DIODE LASER – 3-YEAR RESULTS OF A PROSPECTIVE NON-RANDOMIZED TRIAL
39. Chapter 107 - Molecular Genetic Diagnosis of Neurological Diseases
40. Chapter 79 - Huntington's Disease and Sydenham's Chorea
41. 1093 THE PREDICTION OF INSIGNIFICANT PROSTATE CANCER USING THE PRIAS CRITERIA – ANALYSIS OF 566 CONSECUTIVE SWISS PATIENTS
42. 2268 PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE WITH THE 80-W KTP-LASER VERSUS TRANSURETHRAL RESECTION OF THE PROSTATE &endash; LONG-TERM RESULTS OF A PROSPECTIVE BICENTER TRIAL
43. No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohort
44. LONG-TERM RESULTS OF TRANSURETHRAL KTP- LASER VAPORIZATION OF THE PROSTATE
45. THROMBOPROPHYLAXIS WITH DALTERPARINE FOR TRANSURETHRAL SURGERY, A DOUBLE-BLIND PLACEBO-CONTROLLED, RANDOMISED STUDY
46. Focal Loss of CD44 Variant Protein Expression is Related to Recurrence in Superficial Bladder Carcinoma
47. High-Throughput Tissue Microarray Analysis to Evaluate Genes Uncovered by cDNA Microarray Screening in Renal Cell Carcinoma
48. P4-369: Lithium trial in Alzheimer's disease: A randomized, single-blinded, placebo-controlled, parallel group multicentre 10-week study
49. Endoscopic Management of Bisected Hemidiaphragm During Retroperitoneoscopic Donor Nephrectomy
50. HIGH-POWER POTASSIUM-TITANYL-PHOSPHATE (KTP/532) LASER VAPORIZATION PROSTATECTOMY: 4 YEARS LATER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.